Q1 Results 2024: Hindalco, Hero Motocorp, GMR Airports, Nykaa, Omaxe and over 400 others release Q1 results today

Nishant Pitti, Co-founder and CEO of EaseMyTrip, said, “EaseMyTrip sustained its bottom-line growth during the relevant period, continuing with steady operational momentum along with continued focus on profitability. During Q1 FY2025, the Gross Booking Revenue was Rs 22745 million. Our Revenue from Operations grew by 23.0% Y-o-Y at INR 1526 million. EBITDA had a growth of 34.9%% as compared to Q1 in the previous financial year and was INR 506 million. The PAT had a Y-o-Y increase of 24.8% and was at INR 324.8 million. Gross Booking Revenue from Hotels and Holiday Packages increased by 116.6% year-over-year to INR 210.7 Cr. Subsequently, the company achieved a remarkable 139% year-on-year increase in revenue from its Dubai operations.”

“As per the company’s expansion strategy, EaseMyTrip has opened its offline franchise store model and opened new stores in Karnal, Amritsar, and Bhopal. These additions bring the total number of franchise stores to 16, with a strategic goal of reaching 100 stores by the end of the year,” he added.

Easy Trip Planners Ltd, the parent company of EaseMyTrip, on Tuesday reported fiscal first quarter profit at Rs 33.93 crore, posting a growth of 31.0 per cent in comparison to Rs 25.91 crore during the corresponding quarter of FY24. It posted revenue from operations at Rs 152.60 crore, up 23 per cent as against Rs 124.05 crore during the same period of previous financial year. EaseMyTrip achieved an EBITDA of Rs 50.59 crore in Q1FY25, marking a 34.9 per cent increase compared to the same period last year.

Gross Booking Revenue from Hotels and Holiday Packages increased by 116.6 per cent year-over-year to Rs 210.7 crore. Subsequently, the company achieved 139 per cent year-on-year increase in revenue from its Dubai operations.

Hindustan Foods Ltd on Tuesday reported its fiscal first quarter earnings with profit at Rs 27.25 crore, recording a growth of 16.6 per cent in comparison to Rs 23.37 crore during the corresponding quarter of FY24. It posted revenue from operations at Rs 868.08 crore, up 40.2 per cent as against Rs 619.25 crore during the same period of previous fiscal year. The company EBITDA stood at Rs 72.7 crore, up 44.2 per cent on-year.

Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare Limited, said, “I am delighted to share that we have delivered a strong performance this quarter. Our revenue for Q1 FY25 reached Rs 330.22 crore, marking a robust 15% increase from Rs. 287.17 crore in Q1 FY24. Our EBITDA for the quarter was Rs 93.70 crore, reflecting a growth of 6.9% compared to Rs 87.70 crore in Q1 FY24. Although our PAT for Q1 FY25 was Rs 39.70 crore, a decrease of 4.2% from Rs. 41.50 crore in Q1 FY24, this is attributable to the initial costs associated with our new hospitals. We currently have 2000+ beds including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with custromer delight. We are confident in our ability to drive growth in the upcoming quarters.”

Nykaa has a cumulative customer base of 35 million, up 33 per cent YoY. It has over 67– global and domestic brand partners, wherein it added more than 1500 brands in a year. Nykaa has already achieved the milestone of 200 stores and has 44 warehouses, servicing 98 per cent on pincodes. The company’s consolidated GMV in Q1 came in at $400 million.

Ajay Piramal, Chairman, Piramal Enterprises Ltd, said, “The Q1FY25 results show two important trends that highlight our progress and strategy. First, our Growth business continues to build on the momentum established over the past two to three years, now representing the majority of our Assets Under Management (AUM) and net profit. Second, we continue to reduce our legacy discontinued AUM. Notably, in Q1FY25, the decline of Rs 1,597 crore in legacy AUM had no impact on our profit and loss statement from credit costs. The expansion of our Growth business reflects our strategy to balance growth, risk and profitability as we develop these businesses. Our asset quality remains stable across retail and wholesale products. Further, our Opex-to-AUM - a key driver of profitability - is consistently decreasing. We are also making progress in diversifying our borrowings. We successfully raised our first-ever $300 million dollar bond in July 2024, which received a 4X level of demand. We are pleased to see that the foundations for long term sustainable growth and earnings are firmly in place, and we anticipate that the upcoming quarters will demonstrate a consistent journey along this path.”

Catering: Rs 558.89 crore

Rail neer: Rs 111.47 crore

Internet ticketing: Rs 329.07 crore

Tourism: Rs 124.88 crore

The Board of Hindalco Industries inducted Ananya Birla, and Aryaman Vikram Birla as Directors. Commenting on their appointment, Kumar Mangalam Birla, Chairman, Aditya Birla Group, said, “This is an appropriate moment for the board to induct Ananya and Aryaman as Directors. Given their strong business acumen and sharp focus on sustainability, I am confident that they will provide valuable perspectives that align with Hindalco’s strategic vision for a sustainable future.”

Hindalco Industries Ltd on Tuesday reported profit for the first quarter of FY25 at Rs 3,074 crore, up 25.3 per cent in comparison to Rs 2,454 crore during the corresponding quarter of FY24. The company said that the profit growth was supported by favourable macros, operational efficiencies and lower input costs. It posted revenue from operations at Rs 57,013 crore, up 7.6 per cent as against Rs 52,991 crore during the same period of previous financial year, on account of better realisations and efficiencies in India operations. Consolidated EBITDA came in at Rs 7,992 crore, up 31 per cent YoY.

Kavita Shirvaikar, Managing Director, Patel Engineering Limited, said that the company reported stable and consistent start to the fiscal year despite there being a subdued order inflow in last FY24 and Q1FY25 due to elections and early monsoon at few project sites. “With Patel Engineering Limited meeting expectations in Q1FY25, our commitment to financial excellence has been recognized with the upgrade of our credit rating this quarter to A-. Our focus remains on delivering long-term value for our stakeholders while continuously enhancing operational efficiency and output. With this strong foundation in place, we are poised to build a brighter future for Patel Engineering Limited and create lasting value for India's infrastructure development,” she added.

IPCA Laboratories Ltd on Tuesday recorded its fiscal first quarter earnings with profit at Rs 192.24 crore, up 18.1 per cent in comparison to Rs 162.82 crore during the corresponding quarter of FY24. It posted revenue from operations at Rs 2,092.63 crore, up 32 per cent as against Rs 1,585.21 crore during the same period of previous financial year. The company EBITDA stood at Rs 392.8 crore, up 28 per cent on-year.

A report by JM Financial stated, “Biocon’s 1Q performance was weak. The generics business reported a 6% decline in revenue due to pricing challenges in API and formulations segments. 2Q is likely to remain muted, however 2HFY25 should witness an improvement driven by new launches including liraglutide launch in the UK. Syngene performance was subdued, as discovery services impacted due to the US biotech funding environment. However, management is optimistic of a bounce back in 2HFY25 - RFP traction has improved and is up 50% YoY. Biocon biologics grew 3% YoY (11% YoY like-to-like basis) to INR 20.8bn (3% miss). For BBL, FY25 remains a year of consolidation we project ~13% growth (adjusted for divestments). However, given strong demand across product range in the USA with double digit market share, we remain confident in this segment's future performance which will be driven by new launches and expanding market share in existing products. We have not built any new launches in the US in FY25. Management is reducing debt and tapering capex, thereby improving balance sheet strength. We are positive on the outlook and underlying potential of biosimilars business (enviable pipeline, integrated business, large TAM).”

Deepak Jalan, Managing Director, Linc Limited, said, “We are pleased to state that we have achieved a quarterly total income of Rs 13,144 lakh, marking a 16.1% growth year-over year. Pentonic delivered a 28.6% year-on-year revenue growth in Q1 FY25, resulting in Pentonic contributing 39.6% to our company’s topline in the first quarter of FY25. Our efforts to expand our international presence have paid off, with export and overseas revenue increasing by 26.3% year-over-year in Q1 FY25. Consequently, export sales now account for 18.0% of our topline, up from 16.9% in Q1 FY24. Our Gross Profit Margin stood at 31.2%, reflecting a year-over-year contraction of 108 basis points and a quarter-over-quarter contraction of 128 basis points, primarily due to higher cost of polymers, our key raw material.”

He further added, “We are proud to unveil the Pentonic 75, our latest innovation made with 75% recycled plastic, exemplifying our deep commitment to sustainability. This milestone makes us the first in the industry to achieve 75% circularity, translating to a recycling value of approximately Rs 1.25 per pen. Looking ahead, we are committed to expanding our Total Addressable Market (TAM) by actively pursuing penetration in export markets and swiftly diversifying into adjacent product categories.”